Connect your AI

Integra LifeSciences IART Price / earnings

Price / earnings at other companies

Becton, Dickinson and CompanyBDX

39.3×-4.6×

StrykerSYK

37.7×-12.0×

Globus MedicalGMED

19.9×-34.4×

MiMedx GroupMDXG

19.1×-8.8×

AbbVieABBV

105.8×+17.5×

MedtronicMDT

21.7×-1.5×

Other financials

Income statement

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

Market cap$1.41B+56.2%

Enterprise value$3.15B+22.1%

P/S0.9×+0.3×

Profitability

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

market cap/net income=95.8×

Based on the most recent quarter.

The official record: Integra LifeSciences’s 10-Q, filed July 31, 2025, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Integra LifeSciences's price / earnings?: Integra LifeSciences (IART) reported price / earnings of 95.8× in Q2 2024.
How has Integra LifeSciences's price / earnings changed year-over-year?: Integra LifeSciences's price / earnings increased by 283.6% year-over-year, from 25× to 95.8×.
What is the long-term trend for Integra LifeSciences's price / earnings?: Over 3 years (2020 to 2023), Integra LifeSciences's price / earnings has grown at a 7.0% compound annual growth rate (CAGR), from 41.1× to 50.4×.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.